Correction to: The Potential Proconvulsant Effects of Cannabis: a Scoping Review

Affiliations

¹ Division of Medical Toxicology, Department of Emergency Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. erickacz428@gmail.com.
² Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
³ Department of Emergency Medicine, Maine Medical Center, Tufts University School of Medicine, Portland, ME, USA.
⁴ Departments of Neurology and Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

Published Erratum

Eric E Kaczor et al. J Med Toxicol. 2023 Jan.

. 2023 Jan;19(1):54-60.

doi: 10.1007/s13181-022-00915-1.

¹ Division of Medical Toxicology, Department of Emergency Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. erickacz428@gmail.com.
² Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
³ Department of Emergency Medicine, Maine Medical Center, Tufts University School of Medicine, Portland, ME, USA.
⁴ Departments of Neurology and Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

No abstract available

Erratum for

The Potential Proconvulsant Effects of Cannabis: a Scoping Review.
Kaczor EE, Greene K, Zacharia J, Tormoehlen L, Neavyn M, Carreiro S. Kaczor EE, et al. J Med Toxicol. 2022 Jul;18(3):223-234. doi: 10.1007/s13181-022-00886-3. Epub 2022 Mar 29. J Med Toxicol. 2022. PMID: 35352276 Free PMC article.

1. Bridgeman MB, Abazia DT. Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. Pharm Ther. 2017;42(3):180–188. - PMC - PubMed
1. Barrus DG, Capogrossi KL, Cates SC, et al. Tasty THC: promises and challenges of cannabis edibles. Methods Rep RTI Press. 2016. 10.3768/rtipress.2016.op.0035.1611. - PMC - PubMed
1. Monte AA, Shelton SK, Mills E, Saben J, Hopkinson A, Sonn B, et al. Acute Illness Associated With Cannabis Use, by Route of Exposure. Ann Intern Med. 2019;170(8):531–537. doi: 10.7326/M18-2809. - DOI - PMC - PubMed
1. Vandrey R, Raber JC, Raber ME, Douglass B, Miller C, Bonn-Miller MO. Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products. JAMA. 2015;313(24):2491–2493. doi: 10.1001/jama.2015.6613. - DOI - PubMed
1. Hammond D. Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets. Int J Drug Policy. 2021;91. - PubMed